Total Funding
95
71
Total FundingPost-IPO Equity raised
Growth Score
2 pts
Heat Score
16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
37193
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
- Alexis Howerton: FounderPast Role: Spruce Biosciences, CEO, President
- Javier Szwarcberg: Chief Executive Officer & Board Of DirectorPast Role: BioMarin Pharmaceutical, Group Vice President - Head of Product & Portfolio Development
About the Company
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system. The company is driven by a mission to develop meaningful therapies for patients with rare diseases affecting the hypothalamic-pituitary-adrenal. They are committed to transforming the quality of life for patients who have been
underserved by scientific innovation.
Women Founded
Women Led
